معرفی
Douglas McDonald, MD, PhD is an Assistant Professor of Pediatrics at Harvard Medical School and serves as an Attending Physician in the Division of Immunology at Boston Children’s Hospital. His practice spans multiple locations including Boston, North Dartmouth, Waltham, and Weymouth campuses.
- Formal education: Pennsylvania State University (Undergraduate), Case Western Reserve University School of Medicine (Graduate & Medical), followed by clinical training at Cincinnati Children's Hospital (Internship/Residency) and Boston Children's Hospital (Fellowship)
Research Focus:
Specializes in primary immunodeficiencies, allergic diseases, and Eosinophilic Esophagitis treatment. His work spans molecular immunology (TLR signaling, DOCK8 function) and clinical applications of therapies like dupilumab and interferon treatments.
Publications Trend:
2024 studies on Eosinophilic Esophagitis biologics, 2022 work on TH17 deficiency, 2020 research on MIS-C and CVID, and foundational studies (2010-2016) on DOCK8 deficiency and TLR signaling pathways.
Clinical Affiliation:
Integral member of Boston Children’s Hospital’s Division of Immunology which is:
- Founding site of International Consortium for Immunodeficiency
- FARE Center of Excellence
- FOCIS Center of Excellence
- NIH-funded research leader
Specialized Programs:
Collaborates with multidisciplinary teams in:
- Allergy and Asthma Program
- Immunology Program
- Primary Immunodeficiencies Program
- Eosinophilic Gastrointestinal Disease Program
